Category Specific RSS

Opinion

Finally time to buy Tech and Discretionary stocks?

Something is in the water. The current market environment is nothing like we have seen before. 

High prices, high inflation, high interest rates and now the largest world economy slipping into technical recession. But, now is looking like a good time to buy.

To understand what direction interest rates are heading, Tim and Mike discuss US bond rates, implied inflation rates, yield curve inversions, and how to play this market from an investor’s point of view.

Fear equals selling, which is why we have seen recession fears priced into the tech and discretionary sectors, where investors have seen stocks smash 70-80% lower since February this year. 

So maybe it’s time to get your shopping list ready? When we start to see interest rates stabilising, CPI readings start missing expectations; then, it is time to get a better look at the most beaten down stocks as light comes back into the market. 

In this week’s EFG podcast, Tim and Mike talk about the current state of the market and what it means going forward. Click below to watch.

Emerald Financial

Emerald Financial is a financial services firm founded in 2005. We offer a diversified range of services, including; stock research and data, education courses, portfolio services, and financial news. Over the years, we have educated thousands of Australians to trade equities and derivative markets.

Recent Posts

AML3D announces stronger FY26, with positive EBITDA reported in the second half

Adelaide-based metal printing group books record $12.5 million revenue and a record $78 million sales…

3 days ago

Refurbished tech gives Harris Technology a second life

Harris Technology has found a higher-margin growth engine in an unlikely place: the market for…

4 days ago

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial…

1 week ago

Acrux-developed Menopause Hormone Therapy to enter Australian market

Acrux (ASX:ACR) is set to bring its transdermal Estradiol spray Lenzetto® to the Australian market…

3 months ago

Evion Expands Critical Minerals Push with Nevada Fluorspar Option

The race to secure Western-aligned critical minerals supply chains is accelerating as governments and industry…

4 months ago

Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone

Green360 Technologies (ASX:GT3) has taken a major step forward in the commercialisation of its low-carbon…

4 months ago